Name: iCrea™ ADCC CD20 (-) Target Cell Line, Human Raji Cells [Control]
Availability: InStock

iCrea™ ADCC CD20 (-) Target Cell Line, Human Raji Cells [Control] | Creative Biolabs

iCrea™ ADCC Target CD20 (-) Assay Cell Line are depleted of CD20 expression, to be used as a control for unspecific activation of ADCC that can be a confounding factor when performing ADCC assays. iLite ADCC Target CD20 (-) Assay Cell Line are based on a human B lymphocyte cell line, Raji ( CCL-86), and have been genetically engineered and optimized to be depleted of CD20 expression. The cells are to be use as negative controls together with iCrea™ ADCC Effector (V) Assay Cell Line and iCrea™ ADCC Target CD20 (+) Assay Cell Line for measuring the ADCC activity of anti-CD20 antibodies.